Table 3.
Frequency of K8 variants observed in previously published studies
| Patients cohort | Disease/ controls | #K8 G62C/ # subjects (%) | #K8 R341H/ # subjects (%) | Reference | |
|---|---|---|---|---|---|
| France |
ALC |
261 |
5 (1,9) |
8 (3,1) |
This study |
| Europe |
Controls |
4167 |
65 (1,6) |
- |
[13] |
| Germany |
CHC |
278 |
5 (1,8) |
8 (2,9) |
[18] |
| US |
End-stage liver disease |
274 |
4 (1,5) |
14 (5,1) |
[19] |
| Controls |
268 |
1 (0,373) |
8 (3,0) |
||
| Germany |
ALD |
215 |
4 (1,9) |
- |
[21] |
| Controls |
679 |
12 (1,8) |
|
||
| Germany |
Controls |
560 |
9 (1,6) |
- |
[20] |
| Italy |
PBC |
201 |
4 (2,0) |
8 (4,0) |
[5] |
| Controls |
200 |
0 |
3 (1,5) |
||
| US | ALF | 252 | 4 (1,6) | 18 (7,2) | [6] |
ALC- Alcoholic Liver Cirrhosis, CHC-Chronic Hepatitis C, ALD- Alcoholic Liver Disease, PBC- Primary Biliary Cirrhosis, ALF-Acute Liver Failure.